Delivery Order SPE2DB20D9331-SPE2DB25FL1U1
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 25, 2025, by the Defense Logistics Agency (DLA) for 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used to reverse anticoagulation. The firm fixed-price delivery order has a ceiling value of $19,845.12 with an ultimate completion date of August 15, 2025. This award was issued without a set-aside designation,...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at forty-three thousand six hundred thirty-nine dollars and twenty cents ($43,639.20) by the Defense Logistics Agency. The delivery order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceuticals and medical products to the Defense Logistics Agency. Under this particular delivery order, DMS Pharmaceutical Group will provide five hundred (500)...
- The Defense Logistics Agency awarded a delivery order valued at $18,641.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 1,000 unit vials of Kcentra. This firm fixed-price delivery order, issued on July 28, 2025, with an ultimate completion date of August 18, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,448.32 contract is for the delivery of 1,000 unit vials of the medication Kcentra by February 14, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide...
- DMS Pharmaceutical Group Inc. was awarded a $7,963.75 firm fixed price delivery order against the Defense Logistics Agency's Pharmaceutical Prime Vendor contract to supply 4558578536 units of Kcentra 500 unit vials. The delivery order has a period of performance through October 14, 2022 for delivery to a location in Park Ridge, Illinois. No set-aside provisions were applied to this award to supply the blood factor replacement medication to the Defense Logistics Agency, the Department of...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) for the supply of Kcentra 1,000 unit vials. The order, valued at $17,312.80, is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA for the provision of a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health...
- The Defense Logistics Agency Troop Support Medical awarded a $15,000 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to provide 500 vial units of Kcentra for use by the Department of Defense. DMS Pharmaceutical Group will deliver the pharmaceutical products to a location in Park Ridge, Illinois by August 15, 2023. The Defense Logistics Agency supports military treatment facilities and coordinates the provision of medical supplies and equipment to armed forces personnel...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $13,655.68 order is for 1,000 unit vials of the drug Kcentra, with a performance period through August 7, 2024. The award is made under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to place orders for a wide range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,107.20 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is to provide Kcentra 500unit 1s, a specialized pharmaceutical product, with a period of performance through December 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,609.92, is for the delivery of 1,000-unit vials of the medication Kcentra, with a period of performance through May 17, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1U1Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $9,539.52 by the Defense Logistics Agency on August 18, 2025, for the supply of Kcentra 500 unit vials. The contract carries an ultimate completion date of September 9, 2025, and is not designated under any set-aside program. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide. Kcentra is a vitamin K-dependent clotting factor complex used in emergency medical settings to reverse the effects of anticoagulant therapy. As a critical pharmaceutical product within the Defense Logistics Agency's extensive pharmaceutical supply chain, this delivery order reflects the ongoing demand for specialized medications at military health facilities. DMS Pharmaceutical Group's established position as a key federal pharmaceutical supplier is underscored by its consistent receipt of delivery orders for diverse medical products ranging from vaccines and biologics to oncology treatments and specialty medications, demonstrating the company's significant role in ensuring the availability of essential pharmaceuticals throughout the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 8/18/25 |